MignonL.LohMD
Pediatric Hematology & Oncology • Seattle, WAChief, Division of Pediatric Hematology, Oncology, Bone Marrow Transplant and Cellular Therapy & Director, Ben Towne Center for Childhood Cancer
Dr. Loh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way NE
MB.8.501
Seattle, WA 98105Phone+1 206-987-2106
Summary
- I am a board certified pediatric hematologist-oncologist who specializes in the treatment of children, adolescents, and young adults with high risk leukemia. I am interested in harnessing genomics to add to the accurate diagnosis of leukemia and to utilize this knowledge for optimizing risk stratification and therapeutics.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1995 - 1998- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1992 - 1994
University of California (San Francisco)Internship, Pediatrics, 1991 - 1992
Columbia University Vagelos College of Physicians and SurgeonsClass of 1991
Certifications & Licensure
WA State Medical License 2021 - 2026
CA State Medical License 1999 - 2025
MA State Medical License 1994 - 2001
NC State Medical License 1995 - 1998
NY State Medical License 1994 - 1996
CT State Medical License 1994 - 1995- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 7 citationsCD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia.Astrid Wintering, Kenichi Ishiyama, Stanley Tamaki, Courtney Tamaki, Joshua Fandel
Blood Advances. 2023-01-24 - 7 citationsAssociation of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia.David Spencer Mangum, Julia Meyer, Clinton C. Mason, Soheil Shams, Luke Maese
JAMA Oncology. 2021-10-01 - 32 citationsMEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, Jaishri O Blakeley, Gideon Bollag
Neuro-Oncology. 2022-11-02
Press Mentions
Scientists Identify Genes Linked to Relapse in the Most Common Form of Childhood LeukemiaAugust 12th, 2024
Trametinib Shows Promise for Children with Relapsed or Refractory JMMLJune 13th, 2024
Mignon Lee-Cheun Loh, MDDecember 23rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
